D.E. Shaw & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.74M | Buy |
824,727
+792,331
| +2,446% | +$7.43M | 0.01% | 1193 |
|
|
2025
Q1 | $230K | Sell |
32,396
-1,187
| -4% | -$8.44K | ﹤0.01% | 2735 |
|
|
2024
Q4 | $392K | Buy |
33,583
+21,303
| +173% | +$248K | ﹤0.01% | 2503 |
|
|
2024
Q3 | $252K | Buy |
+12,280
| New | +$252K | ﹤0.01% | 2750 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3393 |
|
|
2023
Q1 | – | Sell |
-15,152
| Closed | -$529K | – | 3492 |
|
|
2022
Q4 | $529K | Sell |
15,152
-36,419
| -71% | -$1.27M | ﹤0.01% | 2694 |
|
|
2022
Q3 | $2.89M | Sell |
51,571
-374,779
| -88% | -$21M | ﹤0.01% | 1895 |
|
|
2022
Q2 | $22.1M | Buy |
426,350
+207,941
| +95% | +$10.8M | 0.03% | 556 |
|
|
2022
Q1 | $15.9M | Buy |
218,409
+215,775
| +8,192% | +$15.7M | 0.01% | 816 |
|
|
2021
Q4 | $311K | Sell |
2,634
-7,398
| -74% | -$873K | ﹤0.01% | 3299 |
|
|
2021
Q3 | $1.35M | Sell |
10,032
-104,960
| -91% | -$14.1M | ﹤0.01% | 2327 |
|
|
2021
Q2 | $18.6M | Sell |
114,992
-288,728
| -72% | -$46.7M | 0.02% | 754 |
|
|
2021
Q1 | $32.4M | Buy |
403,720
+42,349
| +12% | +$3.4M | 0.03% | 521 |
|
|
2020
Q4 | $19.7M | Buy |
361,371
+189,402
| +110% | +$10.3M | 0.02% | 696 |
|
|
2020
Q3 | $3.42M | Sell |
171,969
-22,492
| -12% | -$447K | ﹤0.01% | 1374 |
|
|
2020
Q2 | $4.09M | Buy |
+194,461
| New | +$4.09M | ﹤0.01% | 1262 |
|
|
2020
Q1 | – | Sell |
-12,625
| Closed | -$185K | – | 2791 |
|
|
2019
Q4 | $185K | Buy |
+12,625
| New | +$185K | ﹤0.01% | 2520 |
|